Summary of Jinhe Commercial Management Conference Call Company Overview - Jinhe Commercial Management focuses on non-residential commercial office projects, operating 77 projects with a total management area of approximately 1.4 million square meters [2][6] - The leasing model contributes about 80% of the company's revenue and profit, but also carries operational risks [2][3] Financial Performance - In 2024, the company achieved approximately 1 billion yuan in revenue, but the net profit attributable to shareholders was only over 10 million yuan, primarily due to a goodwill impairment of over 60 million yuan [2][6] - Normalized operating performance is around 1 billion yuan in revenue and 70 to 100 million yuan in net profit [2][6] - Cumulative dividends since listing amount to approximately 700 million yuan [2][6] - The company maintains a healthy cash flow, with operating net cash flow steadily growing at around 100 to 200 million yuan annually [2][7] Business Model and Operations - The company operates under two main business models: leasing operation and entrusted management [3][5] - The leasing operation model involves long-term leases in major cities, where the company assumes operational risks and recognizes full rental income [3][5] - The entrusted management model allows the company to provide property management services without capital investment, primarily earning service fees [3][5] Cost Management - The company has effectively controlled costs through negotiations for rent reductions with major landlords [10] - Major cost items include depreciation and amortization (approximately 70 to 80 million yuan annually) and labor costs (approximately 120 to 160 million yuan annually) [10] - The company employs 520 staff, achieving 1 billion yuan in revenue, resulting in a revenue per employee of 2 million yuan [11] Challenges and Market Conditions - The macroeconomic downturn and pandemic impacts have pressured occupancy rates and rental prices, affecting revenue and profit [2][8] - The company faces challenges such as rising wages for frontline employees, labor shortages, and high turnover rates, with an annual turnover rate of about 20% for frontline staff [11][21] Technological Innovations - The company is exploring the application of robotics in property management, such as floor cleaning robots and drones for exterior cleaning, to improve efficiency and reduce costs [4][12] - It is anticipated that the penetration rate of smart devices in property management could reach 30% in the next three years, potentially saving around 12 million yuan in operating costs [16][17] Future Outlook - The company expects to face ongoing challenges due to high vacancy rates and declining rents in key markets like Shanghai and Beijing [22][23] - The market may be at a bottom stage, with potential for gradual recovery, but this remains to be seen [22][23] - The new leasing standards have impacted reported profits but are expected to stabilize over time, with cash flow remaining strong despite fluctuations in net profit [24][25] Dividend Policy - The company has a long-term dividend policy, with cumulative dividends of 700 million yuan over the past five years, averaging 100 million yuan annually [26] - The current cash reserves exceed 200 million yuan, with stable monthly cash inflows of 90 to 100 million yuan, supporting ongoing dividend payments [26]

创业板风险提示 本次股票发行后拟在创业板市场上市，该市场具有较高的投资风险。创 业板公司具有创新投入大、新旧产业融合成功与否存在不确定性、尚处于成 长期、经营风险高、业绩不稳定、退市风险高等特点，投资者面临较大的市 场风险。投资者应充分了解创业板市场的投资风险及本公司所披露的风险因 素，审慎作出投资决定。 安徽华人健康医药股份有限公司 （Anhui Huaren Health Pharmaceutical Co., Ltd.） （合肥市包河工业区上海路 18 号） 首次公开发行股票并在创业板上市 招股说明书 保荐机构（主承销商） 发行人及全体董事、监事、高级管理人员、发行人控股股东、实际控制人 以及保荐人、承销的证券公司承诺因发行人招股说明书及其他信息披露资料有 虚假记载、误导性陈述或者重大遗漏，致使投资者在证券发行和交易中遭受损 失的，将依法赔偿投资者损失。 声明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对注 册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其对 发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任 何与之相反的声明均属虚假不实陈述。 根据 ...